The presented clinical guideline is focused primarily on the treatment of COVID-19. It also deals with medicinal products that are not recommended for use, organ support, specifics of treatment in children and adolescents, multisystem inflammatory syndrome in children and adolescents (MIS-C, PIMS-TS), pr...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Multiple Sclerosis/therapy,
Multiple Sclerosis/diagnosis,
Ataxia/therapy,
Selective Serotonin Reuptake Inhibitors/therapeutic use,
Fatigue/therapy,
Multiple Sclerosis/rehabilitation,
Fatigue/drug therapy,
Mobility Limitation,
Muscle Spasticity/drug therapy,
Dystonia/drug therapy,
Tremor/drug therapy
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
This guideline covers identifying, treating and managing depression in people aged 18 and over. It recommends treatments for first episodes of depression and further-line treatments, and provides advice on preventing relapse, and managing chronic depression, psychotic depression and depression with a coe...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and mad...
Las leishmaniasis son enfermedades infecciosas desatendidas de gran importancia en la Región de las Américas debido a su morbilidad, mortalidad y amplia distribución geográfica. De las tres formas clínicas principales, la cutánea es la más común y la visceral es la forma más grave, ya que puede ...
Leishmaniasis/drug therapy,
Leishmaniasis/prevention & control,
Antiprotozoal Agents/therapeutic use,
Americas,
Leishmaniasis, Visceral/drug therapy,
Leishmaniasis, Mucocutaneous/drug therapy,
Leishmaniasis, Cutaneous/drug therapy,
Neglected Diseases/drug therapy,
Disease Prevention,
Hyperthermia, Induced/methods,
Paromomycin/therapeutic use
A Grading of Recommendations, Assessment, Development and Evaluation (GRADE) review of the evidence for benefits and harms for Moderna coronavirus disease 2019 (COVID-19) vaccine for children aged 6 months-5 years was presented to the Advisory Committee for Immunization Practices (ACIP) on June 18,...
Grading of Recommendations, Assessment, Development and Evaluation (GRADE) review of the evidence for benefits and harms for Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine for children aged 6 months–4 years was presented to the Advisory Committee for Immunization Practices (ACIP) on ...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released in 2018 ...
A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health services, an...
